https://tenalisibinhibitor.com..../diagnosis-and-manag
MHNW participants, when compared with metabolically healthy or unhealthy obese individuals, presented with elevated FT4 levels, a statistically significant difference (P0.0001), even after adjustment for confounding factors. No variation in TSH levels was noted (P=0.26 across the spectrum of obesity phenotypes. Age-stratified subgroup analysis demonstrated a significant difference in FT4 levels specifically among individuals younger than 55 years (P=0.0001). Individual analyses of
पसंद करना
टिप्पणी
शेयर करना
